![Eyob Alemayehu Gebreyohannes Profile](https://pbs.twimg.com/profile_images/1678966335118905344/x2GYMKUY_x96.jpg)
Eyob Alemayehu Gebreyohannes
@AG_Eyob
Followers
334
Following
1K
Statuses
366
PhD | Pharmacy | Ethiopia πͺπΉ | Australia π¦πΊ | University of South Australia | The University of Western Australia | University of Aberdeen π¬π§
Australia
Joined February 2020
RT @heniget: Delighted to share our latest publication in JPHSR Psychometric testing of two #medicationadherence #PROMs in the Amharic langβ¦
0
3
0
RT @PSA_National: Our Medicine safety: Child and adolescent care report paints a worrying picture of medicine use, including 120,000 kids uβ¦
0
1
0
RT @PSA_National: Today PSA releases the Medicine safety: Child and adolescent care report, revealing the extent of medicine problems in chβ¦
0
7
0
RT @newsGPau: What are the pros and cons of #semaglutide? A new analysis weighs up the increased and decreased risk of health outcomes forβ¦
0
1
0
RT @amhill_physio: Our data show the cost of falls in aged care very high - we need to act @UWA_SAH @MACHAustralia
0
5
0
π¨ New Publication Alert! π¨ The ReMedi Project is live in JMIR Res Protoc! π Weβre co-designing a consumer-focused digital platform to revolutionize the reporting of adverse medicine events (AMEs). π‘ What weβre doing: - Engaging consumers, healthcare professionals, and regulators to co-design a user-friendly platform. - Prototyping and testing innovative solutions for real-world use in general practices and pharmacies. - Empowering consumers to report and manage AMEs while improving data for regulators. π Learn how we aim to improve medication safety and reporting processes: #MedicationSafety #DigitalHealth #Pharmacovigilance #AMEReporting
@DrRenly @QUMPRC
1
2
7
RT @Mohammed_Gebre: Pleased to share the publication of my latest paper, βConsumer views on the use of digital tools for reporting adverseβ¦
0
1
0
Pleased to have led this work on #AnticholinergicBurden and #HRQoL A collaboration between @UniversitySA @AbdnLifeScience @UWA_SAH @UGondar.
Significant association between high anticholinergic burden and diminished HRQoL found among a relatively younger cohort in a resource-limited setting @ProfDerekS @ESCPNews @Filipa_A_C @MatejStuhec @ProfAnitaW
0
0
4
Excited to present my research on Stakeholders views on the Development and Use of a New Digital #AdverseDrugEvent Reporting Platform in Australia at UniSA CHS Emerging Researcher Symposium! Fulltext available from #Drugsafety
@DrRenly
0
0
2
New @UniversitySA research aimed at gauging GP and patient interest on development of a digital tool for reporting adverse drug reactions is hoped to ease rates of under-reporting in Australia.
0
0
1
π’ Could a new digital reporting tool help tackle under-reporting of adverse drug reactions (ADRs)? πOur latest study on the potential impact of a digital ADR reporting platform in Australia is gaining attention! Thank you to @newsGPau for covering our findings. π Read the article: π Check out the coverage: @DrRenly @UWA_SAH @QUMPRC @UniversitySA @TGAgovau
0
1
4
RT @pharmer_jack: π¨ π Medicine shortages π¨π are affecting procurement of medicines for patients, pharmacist workload and motivation and enβ¦
0
4
0